My Healthcare News & Research — June 21, 2026 · Lactulose — The Milk Sugar That Feeds Gut Bacteria and Traps Ammonia

Scientific infographic, a microbe's-eye view of lactulose: gut bacteria ferment it into acids that lower colon pH, converting absorbable ammonia (NH3) into trapped ammonium (NH4+) that leaves in the stool to protect the brain and ease the kidneys, while slowing digestion to flatten the post-meal blood-sugar rise
The lactulose pathway in one picture: a non-digestible milk sugar that human enzymes cannot split, fermented by colon bacteria into acids that lower pH — trapping nitrogen as ammonium, feeding beneficial microbes, and routing waste into the stool instead of the bloodstream. Click to zoom.

Most people meet lactulose on a pharmacy shelf labeled simply “laxative,” and most never look past that label. But lactulose is one of the more scientifically interesting molecules in the medicine cabinet, because it does almost nothing to your body directly. It is not absorbed. It does not stimulate the bowel wall. Your digestive enzymes cannot even break it apart. What it actually does is feed the trillions of bacteria living in your colon — and it is their metabolism, not yours, that produces every one of lactulose’s effects: the softer stool, the gas, the drop in blood ammonia that makes it a frontline liver-failure medicine, and the still-emerging signal that it may lighten the waste load on failing kidneys — and even a newer hint that it may flatten the rise in blood sugar after a meal.

This edition takes lactulose apart from the microbe’s point of view. The thread that ties it all together — and the part most worth understanding — is nitrogen: where ammonia comes from, why an acidic colon traps it, and how a sugar that bacteria eat can end up exporting nitrogen waste into the toilet instead of the bloodstream. That single mechanism is why the same cheap syrup shows up in cirrhosis wards and in kidney-disease research. This expanded edition follows that thread one organ further — into the newest question of whether lactulose’s microbiome effects could help with blood sugar and type 2 diabetes — and then turns practical, covering how lactulose is sold, the different forms it comes in, and how to obtain it in the United States even without insurance.

Table of Contents

  1. 1. What Lactulose Actually Is
  2. 2. Made From Milk Sugar, Not Petroleum
  3. 3. How It Works: Osmosis Plus Fermentation
  4. 4. Lactulose vs. PEG 3350 vs. Kiwifruit
  5. 5. A Prebiotic, Not Just a Laxative
  6. 6. The Ammonia Story — Why Liver Medicine Relies on It
  7. 7. The Gut–Kidney Axis — A Plausible, Emerging Benefit
  8. 8. The Unifying Idea: Lactulose Routes Nitrogen Out of the Body
  9. 9. Lactulose and Blood Sugar — The Type 2 Diabetes Question
  10. 10. Practical Notes: Dosing, Prescription Status, Cautions
  11. 11. How to Get Lactulose in the United States
  12. 12. Types of Lactulose: Syrups, Sachets, and Generics
  13. 13. Buying Lactulose Online: Pharmacies That Ship to the U.S.
  14. Key Research Papers
  15. PubMed Topic Searches
  16. Connections
  17. Featured Videos

1. What Lactulose Actually Is

Lactulose is a synthetic sugar — a disaccharide, meaning two simple sugars joined together. In its case the two halves are galactose and fructose, chemically written as 4-O-β-D-galactopyranosyl-D-fructose. It is a close cousin of lactose, the natural sugar in milk, which is galactose joined to glucose. The only difference is which sugar sits on one half of the molecule and the exact bond that links them — but that small difference is everything.

Humans produce an enzyme (lactase) that splits lactose so we can absorb it. We make no enzyme that can split the galactose–fructose bond in lactulose. So lactulose travels the length of the small intestine essentially untouched, arriving in the colon intact and still carrying all of its chemical energy. That single fact — indigestible by us, but edible by bacteria — is the source of every effect described in this article. Lactulose is best understood not as a drug that acts on you, but as food delivered specifically to your colon’s microbes.

2. Made From Milk Sugar, Not Petroleum

A question we hear often — usually from people trying to avoid petrochemical-derived products — is where lactulose comes from. The answer is reassuring on that count: commercial lactulose is manufactured from lactose, the natural sugar of milk, typically purified from whey, a byproduct of cheese-making. There is no petroleum feedstock in the chain.

The manufacturing logic is elegant. Lactose is galactose-plus-glucose; lactulose is galactose-plus-fructose. Glucose and fructose are isomers — the same atoms arranged differently — so converting one into the other does not require building anything new, only rearranging it. Industrially this is done by alkaline isomerization: lactose is treated under controlled alkaline conditions (often with a catalyst) that flip the glucose half of the molecule into a fructose half, turning lactose into lactulose. The syrup is then purified to remove unreacted lactose and side products. Newer routes use enzymes (such as cellobiose 2-epimerase) or even electrochemical methods to do the same isomerization more cleanly. The takeaway is simple: lactulose is manufactured rather than foraged — it is not abundant in any natural food — but its raw material is a milk sugar, not a barrel of oil.

3. How It Works: Osmosis Plus Fermentation

When lactulose reaches the colon, two things happen at once, and both come from the bacteria.

  1. Fermentation. Gut bacteria consume lactulose as fuel and ferment it into small organic acids — chiefly lactic acid and acetic acid, with smaller amounts of other short-chain fatty acids.
  2. Osmosis. Those acids, plus the un-fermented sugar itself, raise the osmotic pressure inside the colon. Water is pulled into the bowel to balance it. Stool becomes softer, bulkier, and easier to pass.

This is why lactulose is classified as an osmotic laxative — but note that the osmotic effect is partly a downstream product of fermentation, not a purely physical effect. The same fermentation explains the most common complaint: gas, bloating, abdominal rumbling, and mild cramping, especially in the first days of use. If your colon gurgles after a dose, that sound is literally your bacteria metabolizing the sugar — evidence the mechanism is working, even if it is uncomfortable.

One practical consequence of working through bacteria rather than by irritating the bowel: lactulose is not fast. It typically takes 24–48 hours, and sometimes up to 72 hours, to produce its full effect. It does not “force” the bowel the way a stimulant laxative does. People expecting a same-day result from a single dose are often disappointed; lactulose rewards patience and regularity.

4. Lactulose vs. PEG 3350 vs. Kiwifruit

Because readers frequently compare laxative options — particularly those wary of synthetic polymers — here is how lactulose lines up against polyethylene glycol 3350 (PEG, sold as MiraLAX and others) and against the gentle food approach of kiwifruit.

Feature Lactulose PEG 3350
Origin Made from milk sugar (lactose) Petrochemical-derived polymer
Fermented by gut bacteria? Yes — this is the whole point No — chemically inert
Gas and bloating Common Less common
Mechanism Osmotic plus bacterial fermentation Osmotic only
Prebiotic / microbiome effect Yes (feeds beneficial bacteria) Minimal to none
Taste / form Sweet syrup Nearly tasteless powder

The two are genuinely different tools. PEG is an inert polymer: it holds water in the stool and passes through without your bacteria touching it, which is exactly why it causes less gas. Lactulose does the opposite — it is meant to be eaten by your microbes, and the gas is the cost of the microbiome benefit. Neither origin makes one “clean” and the other “toxic”; the honest distinction is mechanistic, not moral. If your priority is avoiding a petroleum-derived compound, lactulose is the milk-sugar option. If your priority is the least possible gas, PEG has the edge.

For mild, occasional constipation, food can do a surprising amount of the work. Randomized trials have found that two green kiwifruit per day improve bowel frequency and stool comfort about as well as some low-dose laxative approaches, working through fiber, water-holding capacity, and gentle continuous fermentation rather than a single osmotic push. A reasonable way to think about it: kiwifruit (or prunes) supports day-to-day regularity; lactulose is the stronger, more predictable intervention when you actually need to move things along.

5. A Prebiotic, Not Just a Laxative

Here is the part the “laxative” label hides. Because lactulose is fermented by bacteria, it meets the textbook definition of a prebiotic: a non-digestible substrate that selectively nourishes beneficial members of the gut community. And the bacteria it favors are the ones most people are trying to cultivate with expensive probiotic products:

As these microbes ferment lactulose, they pour out lactic acid, acetic acid, and short-chain fatty acids, which lower the pH of the colon — making it more acidic. That acidity is itself selective: it favors acid-tolerant beneficial species and suppresses several potentially harmful, pH-sensitive organisms. The result is a measurable shift in the whole ecosystem, not just a bowel movement.

The dose is what separates the two faces of lactulose. A 2021 review in Frontiers in Nutrition by Karakan and colleagues pooled nine clinical trials totaling 537 participants and found that low doses — roughly 5–10 g/day — produce the prebiotic effect (higher Bifidobacterium and Lactobacillus counts, more short-chain fatty acids, lower fecal pH, fewer harmful bacteria) without the strong laxative effect that appears only at the much higher 30–60 g/day doses used for constipation. In a randomized double-blind trial, Bouhnik and colleagues showed that just 5 g twice daily for six weeks significantly raised fecal bifidobacterial counts in healthy adults. Controlled-laboratory gut models confirm the effect is dose-dependent and reproducible.

So someone taking a single 15 mL sachet (about 10 g of lactulose) once a week is, in microbiome terms, giving their Bifidobacterium and Lactobacillus populations a periodic meal — a real, if intermittent, prebiotic dose. The feeling of “working better afterward” that regular users describe is partly the bowel emptying and partly this shift in which bacteria are being fed.

6. The Ammonia Story — Why Liver Medicine Relies on It

This is where the evidence for lactulose is strongest, and where the nitrogen story begins. In advanced liver disease and cirrhosis, the liver can no longer clear ammonia — a nitrogen-rich waste product made largely by gut bacteria as they break down protein. Ammonia builds up in the blood, crosses into the brain, and causes hepatic encephalopathy: confusion, disorientation, tremor, and in severe cases coma. Lactulose is a frontline treatment for it, and the reason is pure chemistry happening in the colon:

  1. The acid trap. Ammonia (NH3) and ammonium (NH4+) exist in a balance that depends on pH. NH3 is a small, uncharged molecule that slips easily across the gut wall into the blood. NH4+ is charged and cannot be absorbed. By fermenting lactulose into acids and dropping colonic pH, lactulose pushes the balance toward NH4+, locking ammonia inside the gut where it cannot reach the brain.
  2. Bacterial uptake. The blooming, well-fed bacteria need nitrogen to build their own bodies, so they pull ammonia out of the gut contents and incorporate it into their biomass. That nitrogen is now inside bacterial cells.
  3. Export in stool. The laxative effect then carries those nitrogen-loaded bacteria, and the trapped ammonium, out of the body in the feces — before the nitrogen can be reabsorbed.

The clinical evidence is unusually solid for a humble syrup. A 2016 Cochrane systematic review by Gluud, Vilstrup, and Morgan pooled 38 randomized controlled trials and found that non-absorbable disaccharides such as lactulose reduced the risk of hepatic encephalopathy (risk ratio 0.58, 95% CI 0.50–0.69) and — remarkably — reduced mortality (risk ratio 0.59, 95% CI 0.40–0.87) compared with placebo or no treatment. The numbers needed to treat were about 6 to improve encephalopathy and 19 to prevent one death. The 2022 EASL clinical practice guidelines accordingly list lactulose as first-line therapy. Whatever else lactulose is, in the liver context it is a genuine, life-saving drug — and it works entirely by managing gut bacteria and nitrogen.

7. The Gut–Kidney Axis — A Plausible, Emerging Benefit

Now the question that prompted this article: if lactulose can lighten the nitrogen burden on the brain in liver failure, could the same trick lighten the waste burden on failing kidneys? The honest answer is: the mechanism is biologically plausible and the early data are encouraging, but this is not established therapy. Here is exactly what is known, graded honestly.

Where the toxins come from

The kidneys clear many waste compounds, and a surprising share of them originate in the gut. Bacteria metabolize dietary amino acids into precursors — indole (from tryptophan) and p-cresol (from tyrosine and phenylalanine) — that are absorbed and converted by the liver into indoxyl sulfate and p-cresyl sulfate. These are called uremic toxins because they accumulate to harmful levels when kidney function declines, and they are linked to faster kidney decline and cardiovascular damage. Crucially, the bacteria that produce indole — certain Bacteroides and Clostridium species — are different from the Bifidobacterium and Lactobacillus that lactulose feeds.

What the studies show

Animal evidence. In a 2019 study in Clinical and Experimental Nephrology, Sueyoshi and colleagues gave lactulose to rats with adenine-induced chronic kidney disease. The treated animals showed lower serum indoxyl sulfate and p-cresyl sulfate, improved serum creatinine and blood urea nitrogen, and significantly less kidney scarring (tubulointerstitial fibrosis). The microbiome explained it: lactulose increased Bifidobacterium and reduced the indole-producing Bacteroides and Clostridium cluster XI — fewer toxin-makers, more beneficial fermenters.

Human evidence. A small randomized trial by Tayebi-Khosroshahi and colleagues (2016) gave 32 patients with stage 3–4 chronic kidney disease either lactulose syrup (30 mL three times daily) or placebo for eight weeks. In the lactulose group, fecal Bifidobacteria and Lactobacilli counts rose significantly, and serum creatinine fell modestly (from 3.90 to 3.60 mg/dL, p = 0.003) while it rose in the placebo group. That is a real, measured signal in actual patients.

The honest limits

Now the part a good skeptic should hold onto. This evidence is one rodent study and one 32-person trial, plus supporting microbiome reviews — not the dozens of large randomized trials that back the liver use. The human creatinine change was modest. Lactulose is not an approved kidney treatment, has not been shown to prevent kidney failure, and nephrologists do not prescribe it for kidney function alone. The right way to read this is as a legitimate, testable hypothesis with promising early support, not a settled benefit. The interesting scientific questions — does it raise Bifidobacterium, increase short-chain fatty acids, lower indoxyl sulfate, and slow decline in large trials? — are measurable, and independent of anyone’s authority. They simply have not all been answered yet at the scale that would change practice.

8. The Unifying Idea: Lactulose Routes Nitrogen Out of the Body

Step back, and the liver use and the kidney hypothesis turn out to be the same mechanism viewed from two ends. Lactulose does not act on the liver or the kidney directly. It acts on bacteria, and through them, on nitrogen routing:

  1. Lactulose reaches the colon undigested and feeds bacteria.
  2. The bacteria multiply, ferment it into acids, and make the colon more acidic.
  3. Growing bacteria pull nitrogen into their own biomass; the acidic environment simultaneously traps ammonia as ammonium so it cannot be absorbed.
  4. The colon becomes a larger “sink” for nitrogen, and the laxative effect exports that nitrogen in the stool.
  5. Less nitrogen-containing waste enters the bloodstream in the first place — whether that waste is the ammonia that poisons the brain in liver failure, or the gut-derived precursors of the uremic toxins the kidneys would otherwise have to clear.

That is the whole idea in one line: lactulose → gut bacteria → nitrogen handling and microbial metabolites → less waste burden entering the circulation. The brain benefit is proven; the kidney benefit is the same lever, applied one organ over, and still being measured.

9. Lactulose and Blood Sugar — The Type 2 Diabetes Question

There is a third frontier where lactulose is being studied, and it surprises almost everyone who hears it: type 2 diabetes. A sweet syrup — a sugar, no less — being investigated to help control blood sugar sounds like a contradiction. It is not, once you remember the rule that governs everything lactulose does: humans cannot digest it. The galactose–fructose bond that our enzymes can’t break is the very reason lactulose does not behave like ordinary table sugar in the bloodstream. It is, in effect, a sugar your body cannot turn into blood glucose.

Unlike the liver and kidney stories — which are two views of one “nitrogen-routing” mechanism — the diabetes story runs on a different set of levers. A 2022 review in Frontiers in Endocrinology by Chu and colleagues gathered the evidence under the title “The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes.” The word potential is doing real work in that title, and we will keep it front and center throughout. Here is what the science actually proposes.

Lever one: slowing the meal down

The most immediate effect concerns the speed of digestion. The review distills it into a single sentence worth unpacking carefully: “A low dose of lactulose with food delayed gastric emptying and increased the whole gut transit times, attenuating the hyperglycemic response without adverse gastrointestinal events.” That one line contains four separate claims, and each translates cleanly into plain language:

If this mechanism sounds familiar, it should. It is the same principle behind several mainstream blood-sugar strategies: eating slowly, front-loading a meal with vegetables or fiber, and the prescription drug class called alpha-glucosidase inhibitors (such as acarbose) all work by the same logic — deliver carbohydrate to the bloodstream more slowly, and the glucose peak shrinks. A smaller peak means less strain on the pancreas and less of the glucose volatility that, repeated three times a day for years, drives much of the long-term damage of diabetes.

Lever two: the microbiome and its hormones

The second lever is the one this whole article has been building toward — the gut bacteria. The metabolic benefit, the review argues, is not merely mechanical slowing; it is the downstream consequence of feeding the right microbes. The chain of events runs like this:

  1. Better bacteria, fewer harmful ones. Similar to acarbose, the review notes, lactulose “can also increase the abundance of the short-chain fatty acid (SCFA)-producing bacteria Lactobacillus and Bifidobacterium as well as suppress the potentially pathogenic bacteria Escherichia coli.” The authors go as far as to say lactulose and acarbose “shared a similar mechanism” — the diabetes drug and the humble laxative may be doing some of the same work on the microbiome.
  2. More short-chain fatty acids. Those well-fed bacteria pour out short-chain fatty acids (SCFAs) — acetate, propionate, and butyrate. SCFAs are not waste products; they are signaling molecules. They nourish the cells lining the colon, strengthen the gut barrier, and are repeatedly linked to improved insulin sensitivity and lower inflammation.
  3. Gut hormones switch on. SCFAs and a healthier gut lining prompt the release of two key hormones — GLP-1 (glucagon-like peptide 1) and PYY (peptide YY). GLP-1 should ring a bell: it is the exact hormone the blockbuster diabetes and weight-loss drugs (the “-glutides”) are built to imitate. It triggers insulin when it is needed, slows the stomach, and curbs appetite — and lactulose appears to nudge the body into making a little more of its own.
  4. Less “leaky-gut” inflammation. A stronger gut barrier means fewer bacterial fragments called lipopolysaccharides (LPS) — endotoxins — slipping into the blood. Circulating LPS is a recognized driver of the low-grade, chronic inflammation that underlies insulin resistance. Less leakage means less inflammation, and a better insulin response.

Put the two levers together and you have the review’s thesis: lactulose may flatten the after-meal spike today (by slowing digestion) while improving the metabolic terrain over time (by reshaping the microbiome and its hormone signals). It is, in the authors’ framing, a prebiotic that happens to pull several of the same levers as real diabetes drugs.

A worked example (illustrative numbers)

To make the “flatter peak” idea concrete, here is a simple before-and-after — with one honest warning up front: these are illustrative numbers chosen to show the principle, not measured results from any specific patient.

Suppose a particular meal would normally push someone’s blood glucose from a fasting 90 mg/dL up to a peak of about 170 mg/dL — rising fast and falling fast. If a small dose of lactulose taken with that meal slows stomach emptying and stretches carbohydrate absorption over a longer period, the same meal might instead produce a slower, gentler rise to roughly 140–150 mg/dL, spread across more time. The total carbohydrate absorbed is similar; what changes is the shape of the curve — a rolling hill instead of a sharp mountain. The exact figures vary enormously from person to person and meal to meal; the only durable takeaway is the shape: a lower, broader peak.

Is a sugar safe for someone who already has diabetes?

This is the obvious worry, and it is exactly the question the paper that prompted this section set out to answer. Commercial lactulose is not chemically pure — manufacturing leaves behind small amounts of free lactose, galactose, and fructose. Could those leftover real sugars spike blood glucose in someone with diabetes and cancel out the benefit?

A 2021 study in the World Journal of Diabetes by Pieber and colleagues tested precisely this. They gave people with type 2 diabetes 20 g and 30 g doses of crystal and liquid lactulose and tracked blood glucose for three hours. The result was reassuring: blood glucose stayed essentially flat, unaffected by the sugar impurities, even through the fasting window after the dose. Their conclusion was that people with type 2 diabetes “may particularly benefit from the prebiotic effect of this laxative without experiencing an impact on blood glucose levels and glycemic management.” In plain terms: for managing constipation or feeding the microbiome, lactulose appears glycemically safe in diabetes — the residual sugars are simply too small a quantity to matter.

Where lactulose sits among proven tools

It helps to place lactulose honestly alongside the strategies that already carry strong diabetes evidence. The point of the table below is not that lactulose equals these tools — it is that lactulose appears to pull some of the same levers, while sitting far lower on the evidence ladder.

Approach Main lever Evidence in diabetes
Diet, weight loss, exercise Improves insulin sensitivity directly Proven — first-line
GLP-1 receptor agonists (“-glutides”) Mimic the GLP-1 hormone Proven — major drug class
Acarbose (α-glucosidase inhibitor) Slows carbohydrate absorption; shifts microbiota Proven — approved drug
Dietary fiber / resistant starch Feeds SCFA-producing microbes; slows absorption Good supportive evidence
Lactulose Slows gastric emptying; raises SCFAs, GLP-1/PYY; lowers LPS Proposed only — no long-term human trials yet

The honest limits — “potential,” not “proven”

Now the discipline this site insists on. The diabetes story sits at an earlier, more tentative stage than even the kidney story, and it must be read that way. The same Frontiers review that proposes the benefit states the limitation plainly: “there is no long-term…lactulose feeding study in subjects with prediabetes or type 2 diabetes.” The gastric-emptying and microbiome findings come largely from healthy volunteers and mechanistic reasoning; the safety study shows lactulose doesn’t harm glucose, not that it prevents diabetes. Stated bluntly:

This is genuinely exciting science, and it is honest to be excited about it — the levers (slower digestion, more SCFAs, more GLP-1, less endotoxin) are real and measurable. It is equally honest to say that the large human trials which would move this from “potential” to “proven” have not been done yet. If you have diabetes or prediabetes, the practical message is narrow and safe: lactulose will not wreck your blood sugar, but it is no substitute for the diet, movement, and medications that are proven to work.

10. Practical Notes: Dosing, Prescription Status, Cautions

Prescription status. In the United States, lactulose oral solution is generally prescription-only (“Rx only”) per FDA-approved labeling. This is largely a quirk of regulatory history — it was approved that way decades ago and no manufacturer pursued the separate process to switch it to over-the-counter — rather than a sign of unusual danger. Lactulose is poorly absorbed and acts locally; in much of Asia and Europe it is sold over the counter or directly by a pharmacist (for example, Duphalac, commonly 10 g per 15 mL sachet). For U.S. readers without insurance, Section 11 covers how to obtain a prescription, Section 12 the product forms you’ll encounter, and Section 13 how to buy it online.

Typical dosing. For constipation, adult dosing often starts at 15–30 mL daily (about 10–20 g) and is adjusted to response; for hepatic encephalopathy, doses are higher and titrated to produce two to three soft stools per day. For prebiotic effect, the research above points to a much lower ~5–10 g/day. Remember the 24–72 hour onset — it is not a same-day fix.

A gentle correction worth making. Regular users often say lactulose “cleans out the intestine.” Physiologically that is not quite what happens — lactulose does not scrub the gut wall or remove “toxins” in the detox sense. It draws in water, softens and bulks the stool, and shifts which bacteria and metabolites dominate, which helps the bowel empty more completely and comfortably. That can feel like being cleaned out, and it is a real and useful effect — it is just worth naming accurately.

Cautions. Lactulose contains galactose and small amounts of other sugars, so it is contraindicated in galactosemia (an inherited inability to handle galactose). People with diabetes should be aware it contains some free sugars, though the glycemic impact is usually small. The fermentation-driven gas, bloating, and cramping are the most common nuisances and often ease with time or a lower starting dose. Overuse can cause diarrhea and, with significant fluid loss, electrolyte disturbance — a particular reason for people with advanced kidney disease to use it only under medical guidance. As always on this site: this article is education, not a prescription — decisions about using lactulose for any medical condition belong with you and your clinician.

11. How to Get Lactulose in the United States

Because lactulose is so cheap, safe, and useful, a practical question follows naturally: how do you actually get it? The answer depends entirely on where you live. In much of Asia, Europe, and Latin America, lactulose is sold over the counter — you can buy it straight from a pharmacist without seeing a doctor. In the United States it is prescription-only, a status that (as Section 10 explained) reflects regulatory history more than any real danger. For people with a regular doctor this is a non-issue. For the uninsured, or anyone without an established physician, it can be a genuine barrier — so this section lays out the legitimate routes to a prescription.

A number of telehealth services let you pay cash for a brief online consultation and, if a clinician agrees it is appropriate, receive a prescription sent to the pharmacy of your choice. No insurance is required at any of them. The product a clinician typically prescribes is the oral solution, 10 g per 15 mL (sold generically and under U.S. names such as Cholac, Constulose, Enulose, Generlac, and the crystalline powder Kristalose). Options that patients commonly use include:

For most people the most direct path is to start at a service that lists lactulose by name — search “lactulose,” book the visit, and ask for the oral solution, 10 g/15 mL. Once you hold a valid prescription you can fill it at any U.S. pharmacy; Section 13 covers online options for filling it as well.

12. Types of Lactulose: Syrups, Sachets, and Generics

Walk into a pharmacy anywhere in the world and the lactulose on the shelf will look more varied than it really is. Almost all of it is the same molecule at the same strength; what differs is the packaging, the brand, and a few details of purity. Here is how to read the options, using products sold across Asia and Europe as examples. (We list no prices — they vary by country and change constantly; this is purely about the forms you will encounter.)

One standard strength

The overwhelming majority of lactulose products deliver 10 g of lactulose per 15 mL — equivalently labeled 667 g/L or 670 mg/mL. Whether the box reads Duphalac, Laevolac, Lactulose Stella, or a local generic, that 10 g-per-15 mL concentration is the near-universal default. This is why dosing instructions translate cleanly across brands and borders: “15 mL” means roughly 10 g almost everywhere.

Three delivery formats

The real choice is how that syrup is packaged, and there are three common formats:

Originator brand versus generics

Duphalac is the long-established originator brand and the name many clinicians reach for out of habit. But because lactulose is old and off-patent, there are many equally valid generics — Lactulose Stella, Lactulin (Meyer), Laevolac, Companity, Pharmedic lactulose, and others depending on the country. A generic at the same 10 g/15 mL strength is the same medicine; the choice between brand and generic is about price and availability, not effectiveness.

A note on purity and “extra” sugars

One genuine difference between products is how much residual sugar they carry. Some inserts (Laevolac, the Duphalac solution) state no added excipients, while noting that tiny amounts of lactose, galactose, and fructose can remain from manufacturing. For most people this is irrelevant. It matters in the two situations covered earlier: diabetes (where the Pieber study found these residual sugars too small to move blood glucose) and galactosemia (where lactulose is contraindicated because even trace galactose is a problem).

What lactulose is not bundled with

Finally, a clarification that heads off a common shopping mistake. Lactulose is sold as a single-ingredient product. There is no widely available all-in-one sachet that combines lactulose with psyllium, fiber, or probiotics in the same package. Combination “fiber + probiotic” supplements do exist (for example, Physician’s Choice Fiber + Probiotic), but they do not contain lactulose — they are a different product for a different purpose. If you want both lactulose and a fiber-or-probiotic, you buy them separately. (For food-based fiber that ferments similarly, see resistant starches and probiotic foods.)

13. Buying Lactulose Online: Pharmacies That Ship to the U.S.

Once you have a prescription (Section 11), filling it is straightforward at any local U.S. pharmacy. Some patients, though, look to international online pharmacies — usually to find larger bottle sizes or lower cash prices. A few that list lactulose and state that they ship to the United States are below. Because lactulose dosing is standardized at 10 g/15 mL, the products are comparable; what differs is bottle size, price, and shipping. We describe only what each site states about itself and, again, list no prices.

One important legal caveat, stated plainly. The U.S. Food and Drug Administration considers importing prescription medication from another country for personal use to be generally prohibited, with only limited case-by-case exceptions. That means a shipment can be stopped by U.S. Customs even when the online pharmacy accepts your order and charges your card. The FDA explains its position on personal importation here. For most people the simpler, lower-risk path is a U.S. prescription (Section 11) filled at a domestic pharmacy.

A note on neutrality. My Healthcare is a free, non-profit public-good project. We have no affiliation with, and earn nothing from, any telehealth service or pharmacy named in Sections 11–13. They are listed for information only, are not endorsements, and may change their terms at any time. Verify a pharmacy’s licensing — for instance through your state board of pharmacy or a verification program such as the U.S. NABP — before sending money or personal health information, and make decisions about lactulose with a clinician who knows your history.

Key Research Papers

Prebiotic & Gut-Bacteria Effects

  1. Karakan T, Tuohy KM, Janssen-van Solingen G. Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption. Frontiers in Nutrition. 2021;8:672925. doi:10.3389/fnut.2021.672925 (PMID 34386514)
  2. Bouhnik Y, Attar A, Joly FA, et al. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. European Journal of Clinical Nutrition. 2004;58(3):462–466. doi:10.1038/sj.ejcn.1601829
  3. Bothe MK, Maathuis AJH, Bellmann S, et al. Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine. Nutrients. 2017;9(7):767. doi:10.3390/nu9070767 (PMID 28718839)

Ammonia & Hepatic Encephalopathy (Strongest Evidence)

  1. Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews. 2016;(5):CD003044. doi:10.1002/14651858.CD003044.pub4 (PMID 27089005)
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. Journal of Hepatology. 2022;77(3):807–824. doi:10.1016/j.jhep.2022.06.001

Gut–Kidney Axis & Uremic Toxins (Emerging Evidence)

  1. Sueyoshi M, Fukunaga M, Mei M, et al. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clinical and Experimental Nephrology. 2019;23(7):908–919. doi:10.1007/s10157-019-01727-4 (PMID 30895529)
  2. Tayebi-Khosroshahi H, Habibzadeh A, Niknafs B, et al. The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial. Journal of Renal Injury Prevention. 2016;5(3):162–167. doi:10.15171/jrip.2016.34

Metabolic Health & Type 2 Diabetes (Emerging Evidence)

  1. Chu N, Ling J, Jie H, Leung KS, Poon ETC. The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes. Frontiers in Endocrinology. 2022;13:956203. doi:10.3389/fendo.2022.956203 (PMID 36187096)
  2. Pieber TR, Svehlikova E, Mursic I, et al. Blood glucose response after oral lactulose intake in type 2 diabetic individuals. World Journal of Diabetes. 2021;12(6):893–907. doi:10.4239/wjd.v12.i6.893 (PMID 34168736)

Chemistry & Manufacture

  1. Karim A, Aïder M. Sustainable Electroisomerization of Lactose into Lactulose and Comparison with the Chemical Isomerization at Equivalent Solution Alkalinity. ACS Omega. 2020;5(5):2318–2333. doi:10.1021/acsomega.9b03705

PubMed Topic Searches

  1. PubMed: lactulose prebiotic Bifidobacterium
  2. PubMed: lactulose hepatic encephalopathy ammonia
  3. PubMed: lactulose chronic kidney disease uremic toxins
  4. PubMed: indoxyl sulfate p-cresyl sulfate gut microbiota
  5. PubMed: gut-kidney axis chronic kidney disease
  6. PubMed: lactulose short-chain fatty acids colonic pH
  7. PubMed: lactulose type 2 diabetes glucose
  8. PubMed: lactulose microbiota GLP-1 SCFA

Connections

Back to Table of Contents